720-777-0123
Immunosuppressive medications play a vital role in helping heart transplant recipients’ bodies accept their new organs. But while some drugs assist a new heart, they can also damage kidney function. That’s where Melvin Chan, MD, comes in. As one of the first graduates from the Pediatric Nephrology Fellowship at the University of Colorado School of Medicine, Dr. Chan is looking into risk factors that affect long-term kidney function and implementing standardized protocols to reduce these risks. Dr. Chan aims to help heart transplant patients with reduced kidney function live longer lives and further use his research to foster multidisciplinary collaboration across all areas of medicine.
“I am passionate about providing comprehensive care for patients, with a focus on disease prevention. I strive to work with each patient and their families to improve understanding and meet their health goals.”
- MELVIN CHAN, MD
